Now that we are over 10 years into the HAART era in resource-rich countries the major
clinical impact of this therapy on reduced AIDS events and AIDS deaths has been well …

The EuroSIDA study was initiated in 1994 and follows adult people living with HIV (PLHIV) in
100 collaborating clinics across 35 countries covering all European regions, Israel and …

Improved methods for targeting HIV testing among patients most likely to be infected are
required; HIDES I aimed to define the methodology of a European wide study of HIV …

Background Combination antiretroviral therapy (cART) has been shown to reduce mortality
and morbidity in patients with HIV. As viral replication falls, the CD4 count increases, but …

Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a
cross-European update from 34 countries on the prevalence and risk factors of LP for 2010 …

European guidelines recommend the routine offer of an HIV test in patients with a number of
AIDS-defining and non-AIDS conditions believed to share an association with HIV; so called …

Background Triple-combination antiretroviral therapy (CART) for human immunodeficiency
virus infection has been in use for almost a decade, but the extent to which treatment …

Objectives: To determine prevalence and characteristics of end-stage renal diseases
(ESRD)[dialysis and renal transplantation (RT)] among European HIV-infected patients …

Objectives: HIV is a major public health problem among MSM in the United Kingdom with
around 2400 new infections annually. We quantified the contribution of biological and …

When should antiretroviral therapy for HIV be started? | The BMJ Skip to main content Intended
for healthcare professionals Access provided by Google Indexer Subscribe My Account My …